The effectiveness of radiation therapy for lung cancer treatment can be significantly improved if radiation dose can be safely escalated. The main limitation to dose escalation is tumor location uncertainty during treatment due to patient respiration. In addition to geometric changes, tumor hypoxia is a leading cause of treatment failure. If dose can be escalated to radioresistant hypoxic regions then local tumor control would also improve. RefleXion Medical is using positron emission tomography (PET) to guide radiation delivery so that both geometric and biological changes in the tumor can be accounted for in real-time during treatment. In Phase I of the project we aim to: 1) Develop a method of directing radiation beam-lets along individual PET lines-of- response;2) Develop a method of estimating target position using subsets of PET emissions that occur over a short period of time;and 3) Test methods developed in Aims 1 and 2 using list-mode PET data acquired from a moving phantom.
Aim 3 experiments will be accomplished at the Stanford Cancer Center utilizing a motion phantom and a PET-CT system. In Phase II we plan to directly control a multi-leaf collimator using a motion phantom and PET detector table-top system so that tumor tracking can be demonstrated experimentally. The developed treatment methods for real-time PET-guided radiation therapy may result in significantly more effective treatments through safe dose escalation and optimal distribution of the dose to the heterogeneous moving tumor.

Public Health Relevance

Lung cancer is the biggest cancer killer in both men and women in the U.S. While two-thirds of U.S cancer patients are treated with radiation therapy, success rates for lung cancer are low, largely due to movement of the tumor during breathing. In this project, RefleXion Medical aims to develop a radiotherapy system that uses positron emission tomography (PET) to non-invasively track a tumor's position and biological state during treatment. Real-time PET-guided radiotherapy will enable safe dose escalation and smarter dose distribution, leading to more effective treatment of tumors that exhibit significant motion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA153466-01A1
Application #
8057371
Study Section
Special Emphasis Panel (ZRG1-OTC-R (11))
Program Officer
Narayanan, Deepa
Project Start
2011-09-26
Project End
2013-08-31
Budget Start
2011-09-26
Budget End
2013-08-31
Support Year
1
Fiscal Year
2011
Total Cost
$260,006
Indirect Cost
Name
Reflexion Medical, Inc.
Department
Type
DUNS #
831659169
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Yang, Jaewon; Yamamoto, Tokihiro; Mazin, Samuel R et al. (2014) The potential of positron emission tomography for intratreatment dynamic lung tumor tracking: a phantom study. Med Phys 41:021718
Fan, Qiyong; Nanduri, Akshay; Yang, Jaewon et al. (2013) Toward a planning scheme for emission guided radiation therapy (EGRT): FDG based tumor tracking in a metastatic breast cancer patient. Med Phys 40:081708
Fan, Qiyong; Nanduri, Akshay; Mazin, Samuel et al. (2012) Emission guided radiation therapy for lung and prostate cancers: a feasibility study on a digital patient. Med Phys 39:7140-52